Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Rezolve AI Stock Is Rising Today (Fool) +++ REZOLVE AI Aktie -4,05%

ACCENDRA HEALTH Aktie

 >ACCENDRA HEALTH Aktienkurs 
1.89 EUR    (TradegateBSX)
Ask: 1.9 EUR / 5260 Stück
Bid: 1.88 EUR / 5330 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
OWENS MINOR Aktie über LYNX handeln
>ACCENDRA HEALTH Performance
1 Woche: +7,7%
1 Monat: -10,3%
3 Monate: -19,1%
6 Monate: -56,3%
1 Jahr: -76,9%
laufendes Jahr: -22,9%
>ACCENDRA HEALTH Aktie
Name:  ACCENDRA HEALTH (OWENS & MINOR)
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US6907321029 / 904611
Symbol/ Ticker:  6OM (Frankfurt) / ACH (NYSE)
Kürzel:  FRA:6OM, ETR:6OM, 6OM:GR, NYSE:ACH
Index:  -
Webseite:  https://www.owens-minor.c..
Profil:  Accendra Health, Inc. is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people annually. The company connects patients, providers, and insurers through innovative solutions ..
>Volltext..
Marktkapitalisierung:  138.83 Mio. EUR
Unternehmenswert:  1743.79 Mio. EUR
Umsatz:  4101.86 Mio. EUR
EBITDA:  347.38 Mio. EUR
Nettogewinn:  -956.46 Mio. EUR
Gewinn je Aktie:  -12.42 EUR
Schulden:  1880.06 Mio. EUR
Liquide Mittel:  245.05 Mio. EUR
Operativer Cashflow:  -88.46 Mio. EUR
Bargeldquote:  0.3
Umsatzwachstum:  -61.12%
Gewinnwachstum:  -167.48%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  14.12.21 - 0.0021449998€
14.09.21 - 0.0021449998€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ACCENDRA HEALTH, OWENS & MINOR, OWENS MINOR
Letzte Datenerhebung:  30.03.26
>OWENS MINOR Kennzahlen
Aktien/ Unternehmen:
Aktien: 76.44 Mio. St.
Frei handelbar: 96.22%
Leerverk. Aktien: -
Rückkaufquote: 6.37%
Mitarbeiter: 6500
Umsatz/Mitarb.: 0.37 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 65.32%
Bewertung:
KGV: -
KGV lG: 3.52
KUV: 0.03
KBV: -
PEG-Ratio: -
EV/EBITDA: 5.02
Rentabilität:
Bruttomarge: 28.43%
Gewinnmarge: -2.62%
Operative Marge: 3.19%
Managementeffizenz:
Gesamtkaprendite: -3.48%
Eigenkaprendite: -237.61%
>OWENS MINOR Peer Group
Gesundheit, Diabetes- & Adipositas- Behandlung, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
30.03.26 - 16:36
Owens & Minor Appoints Chief Products Officer (PR Newswire)
 
Colin Bain brings extensive leadership expertise in rapidly innovating and successfully implementing go-to-market strategies in medical device and product manufacturing RICHMOND, Va., March 30, 2026 /PRNewswire/ -- Owens & Minor, a global healthcare solutions company providing essential......
13.03.26 - 15:00
Is the Options Market Predicting a Spike in Accendra Health Stock? (Zacks)
 
Investors need to pay close attention to Accendra Health stock based on the movements in the options market lately....
05.02.26 - 22:09
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call (Business Wire)
 
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above. About Accendra Health, Inc. Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology and services that support health beyond the hospital for millions of people each...
04.02.26 - 21:01
Owens & Minor Names New Chief Commercial Officer (PR Newswire)
 
Industry veteran Dirk Benson brings over three decades of experience in healthcare supply chain manufacturing and distribution with a focus on commercial excellence RICHMOND, Va., Feb. 4, 2026 /PRNewswire/ -- Owens & Minor today named longtime industry leader Dirk Benson to the role of......
08.01.26 - 16:00
Implied Volatility Surging for Accendra Health Stock Options (Zacks)
 
Investors need to pay close attention to ACH stock based on the movements in the options market lately....
31.12.25 - 22:21
PLATINUM EQUITY COMPLETES ACQUISITION OF OWENS & MINOR PRODUCTS & HEALTHCARE SERVICES BUSINESS (PR Newswire)
 
P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growing the business P&HS will retain Owens & Minor brand and operate as a standalone company in Platinum's portfolio LOS ANGELES, Dec. 31, 2025 /PRNewswire/ -- Platinum Equity announced......
31.12.25 - 22:09
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity (Business Wire)
 
The Transaction Includes the Owens & Minor Brand, and the Remaining Company Will Become Accendra Health Completes the Company's Transformation into a Pure Play Leader in the Home-Based Care MarketRICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. “Today's announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform. The completion of the sale of the P&HS segment enables the Company to become a more focused and resilient organization that is well equipped to deliver on our commitment to supporting patients with chronic conditions by providing what they need for home-based care. We're energized by what lies ahead and are confident that our comprehensive product...
18.12.25 - 22:24
Owens & Minor to rebrand as Accendra Health, change ticker to “ACH” (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.12.25 - 23:42
Moody′s stuft Owens & Minor nach Spartenverkauf auf B2 herab (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.12.25 - 16:00
Do Options Traders Know Something About Owens & Minor Stock We Don′t? (Zacks)
 
Investors need to pay close attention to Owens & Minor stock based on the movements in the options market lately....
31.10.25 - 00:15
Owens & Minor outlines pure-play home-based care focus with $2.76B–$2.82B 2025 revenue guidance amid major divestiture (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 23:24
Owens & Minor Q3 2025: Umsatz steigt, doch Aktie gibt nach (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 17:30
Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for (Zacks)
 
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
16.10.25 - 12:33
Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call (Business Wire)
 
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above. About Owens & Minor Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens ...
10.10.25 - 16:00
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity (Zacks)
 
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake....
07.10.25 - 22:48
Owens & Minor-Aktie schießt nach Verkauf des P&HS-Segments in die Höhe (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.10.25 - 22:42
Owens & Minor sells products & healthcare services unit to Platinum Equity (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.10.25 - 22:24
PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR (PR Newswire)
 
Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth Owens & Minor to retain a 5% equity stake in the business LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Platinum Equity announced today that it has entered into a definitive......
07.10.25 - 22:18
Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake (Business Wire)
 
Transforms Owens & Minor into a Pure Play Market Leader in the Home-Based Care Market 5% Retained Equity Stake Provides Ability to Realize Future Value Creation Under Platinum Equity Preserves Tax Attributes in Excess of $150 MillionRICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced that it has entered into a definitive agreement for the sale of the Company's Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the Company to focus on a simpler business model and allow for a more appropriate valuation as a leader in this segment. “Today's announcement represents another critical step forward in the strategic transformation of Owens & Minor into a leading, pure play home based care platform,” said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor. “Wit...
15.08.25 - 07:01
Insiderhandel: Insider kauft Aktien von Owens & Minor im Wert von 2617044 USD (Insiderkauf)
 
Coliseum Capital Management, LLC - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2025-08-14...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Tiefe des menschlichen Herzens läßt sich nicht ausloten. - Sprichwort China
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!